Medical Aesthetics
Found 3 recent publications
With a push from the Kardashians: How the "dream" company became a rare phenomenon on the Tel Aviv Stock Exchange
The medical aesthetics company that joined the stock exchange in the 2021 IPO wave has, unlike most, become a profitable and growing cash generator. With a patented technology, a recurring revenue model, and global deployment, it has broken the streak of disappointments that the sector has yielded. Will it also overcome increasing competition and regulatory changes? Company analysis.
Sofwave Stock Surges 320%: How the Israeli Company Rides the Ozempic Wave
Medical aesthetics company Sofwave has become a standout performer on the Tel Aviv Stock Exchange. The stock has climbed 48% since the start of 2026 and 320% over the last three years, bringing the company's market value to approximately 1.48 billion shekels.
Israeli Company Sofwave Reports Record Financial Results
Sofwave reveals strong financial reports with revenues of approximately 30 million dollars in the second quarter of 2026, alongside a 66% jump in net profit despite one-time expenses.